PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

Clinical trial NCT05161728 · UNKNOWN

Trial details

NCT number: NCT05161728
Sponsor: Roderick van den Bergh
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2021-10-19
Primary completion: 2025-10-19
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.